(Q36842777)

16 August 2017

1 reference

title

Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection (English)

1 reference

16 August 2017

1 reference

Alberto Breda

1

1 reference

PubMed ID

17555395

16 August 2017

Ramdev Konijeti

series ordinal

2

1 reference

PubMed ID

17555395

16 August 2017

John S Lam

series ordinal

3

1 reference

16 August 2017

1 June 2007

1 reference

Expert Review of Anticancer Therapy

16 August 2017

1 reference

16 August 2017

7

1 reference

16 August 2017

6

1 reference

16 August 2017

847-862

1 reference

16 August 2017

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Rising incidence of renal cell cancer in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Advances in immune-based therapies of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

RENAL CELL CARCINOMA: PROGNOSTIC SIGNIFICANCE OF INCIDENTALLY DETECTED TUMORS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Solid renal tumors: an analysis of pathological features related to tumor size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

The natural history of observed enhancing renal masses: meta-analysis and review of the world literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Management of renal masses in patients medically unsuitable for nephrectomy--natural history, complications, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Clinicopathological study of clear-cell tumors of the thyroid: an evaluation of 22 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Solitary breast mass as initial presentation of clinically silent metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Metastatic hypernephroma masquerading as acute cholecystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Various features and surgical approach of solitary pancreatic metastasis from renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Metastases from renal cell carcinoma presenting as gastrointestinal bleeding: two case reports and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Sarcomatoid renal cell carcinoma metastatic to the heart: report of a case

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Metastatic renal cell carcinoma to the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Vaginal metastasis as the first sign of renal cell carcinoma. A case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

The role of lymphadenectomy in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Tumor size improves the accuracy of TNM predictions in patients with renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Eastern Cooperative Oncology Group performance status predicts bone metastasis in patients presenting with renal cell carcinoma: implication for preoperative bone scans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Gamma knife surgery for metastatic brain tumors from renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Renal cell carcinoma: analysis of postoperative recurrence patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Low clinical stage renal cell carcinoma: relevance of microvascular tumor invasion as a prognostic parameter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Paraneoplastic Signs and Symptoms of Renal Cell Carcinoma: Implications for Prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Cachexia-like symptoms predict a worse prognosis in localized t1 renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Role of molecular markers in the diagnosis and therapy of renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

The survivin:fas ratio in pediatric renal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Prognostic assessment of nonmetastatic renal cell carcinoma: a clinically based model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

A review on follow-up strategies for renal cell carcinoma after nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Cryotherapy: clinical end points and their experimental foundations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Scleromyxoedema-like cutaneous diseases in renal-dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Positron emission tomography in urological oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Treatment of spinal metastases from kidney cancer by presurgical embolization and resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Hepatic resection for metastatic renal tumors: is it worthwhile?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Surgical resection of brain metastases from renal cell carcinoma in 50 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Surgical treatment of brain metastases from renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Clinical study of brain metastasis of renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Isolated local recurrence of renal cell carcinoma after radical nephrectomy: experience with 10 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

Treatment of osseous metastases in patients with renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.6.847

21 January 2018

Identifiers

DOI

10.1586/14737140.7.6.847

1 reference

16 August 2017

1 reference

PubMed ID

17555395